Perissos Private Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$384K Buy
332
+8
+2% +$9.44K 0.25% 56
2026
Q2
$389K Buy
324
+35
+12% +$35.8K 0.26% 55
2026
Q1
$266K Hold
289
– – 0.23% 58
2025
Q4
$310K Hold
289
– – 0.27% 53
2025
Q3
$220K Buy
289
+1
+0.3% +$744 0.16% 74
2025
Q2
$225K Hold
288
– – 0.18% 66
2025
Q1
$238K Hold
288
– – 0.22% 63
2024
Q4
$223K Sell
288
-164
-36% -$136K 0.17% 80
2024
Q3
$401K Buy
+452
New +$406K 0.32% 59

Other funds holding LLY

Perissos Private Wealth Management's LLY Position: Q3 2026 in Review

Perissos Private Wealth Management increased its Eli Lilly (LLY) stake by 2.5% in Q3 2026, buying an estimated $9.44K and bringing the position to 332 shares worth $384K. The position accounts for 0.25% of the portfolio, ranked #56.

Perissos Private Wealth Management first reported a position in LLY in Q3 2024 and has held it in 9 quarters since. The position peaked at $401K in Q3 2024. 4,628 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Perissos Private Wealth Management held 332 shares of Eli Lilly worth $384K as of Q3 2026.
  • Perissos Private Wealth Management bought 8 Eli Lilly shares in Q3 2026, an estimated $9.44K.
  • Eli Lilly made up 0.25% of Perissos Private Wealth Management's portfolio in Q3 2026, its #56 holding.
  • Perissos Private Wealth Management first reported a position in Eli Lilly in Q3 2024 and has held it in 9 quarters since.
  • Perissos Private Wealth Management's Eli Lilly position peaked at $401K in Q3 2024.
  • 4,628 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Perissos Private Wealth Management's 13F filing for Q3 2026, filed 13 Nov 2026.